Gilead Sciences to Present at Two Upcoming Investor Conferences
February 23 2011 - 4:30PM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the
company will be webcasting its corporate presentation at two
upcoming investor conferences: the RBC Capital Markets’ Healthcare
Conference and the Citi Global Healthcare Conference, both taking
place in New York.
John F. Milligan, PhD, Gilead’s President and Chief Operating
Officer, and Robin Washington, Gilead’s Chief Financial Officer,
will provide an overview of the company at the RBC conference on
Wednesday, March 2 at 11:00 a.m. Eastern Standard Time (EST) and
the Citi conference on Thursday, March 3 at 11:00 a.m. EST.
To access the live webcasts via the internet log on to
www.gilead.com. Please connect to the company’s website at least 15
minutes prior to each live presentation to ensure adequate time for
any software download that may be necessary to listen to the
webcast.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company's mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Australia.
For more information on Gilead Sciences, please
visit www.gilead.com orcall the Gilead Public Affairs Department at
1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jul 2023 to Jul 2024